May 2026 Corvention received U.S. FDA 510(k) clearance for the KardiaPsi Balloon Catheter, engineered for ultrahigh-pressure inflation during treatment of heavily calcified lesions and designed for rapid inflation and deflation using a single inflation device.
July 2025 Teleflex completed the EUR 760 million acquisition of BIOTRONIK's Vascular Intervention business, adding balloon catheters and other coronary and peripheral interventional devices to its portfolio.